Patents by Inventor Nicholas Catsimpoolas
Nicholas Catsimpoolas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5066496Abstract: Ganglioside mixtures and/or lipid mixtures e.g. from brain and omentum, are found to be effective to treat peptic ulcers.Type: GrantFiled: August 3, 1988Date of Patent: November 19, 1991Assignees: Angio-Medical Corporation, Trustees of Boston UniversityInventors: Sandor Szabo, Meryl S. A. Rubin, Michael Klibaner, Ahmad R. Kamarei, Robert S. Sinn, Nicholas Catsimpoolas
-
Patent number: 4990333Abstract: Factors isolated from omental extracts are used to promote bone healing, for example in fractures in mammals.Type: GrantFiled: December 20, 1985Date of Patent: February 5, 1991Assignees: Angio Medical Corporation, Trustees of Boston UniversityInventors: Joseph Lane, Nicholas Catsimpoolas, Robert S. Sinn
-
Patent number: 4957741Abstract: Lipid material or ganglioside from mammalian sources e.g. bovine and porcine brain or omentum is used to treat peptic ulcers.Type: GrantFiled: August 2, 1988Date of Patent: September 18, 1990Assignee: Angio-Medical Corp.Inventors: Ahmad R. Kamarei, Nicholas Catsimpoolas, Robert McCluer, Takashi Mise, Robert S. Sinn
-
Patent number: 4921838Abstract: A method for enhancing angiogenesis and/or blood vascular perfusion in mammals by administering a pharmacologically effective amount of specific angiogenically active non-ionic, anionic, cationic and zwitterionic amphiphilic compounds. An angiogenically effective amount of the angiogenically active compound digitonin is in the range of at least 1.25 microgram to at least 200 microgram of digitonin. The range including enhancement of vascular perfusion is up to 50 mg of digitonin.Type: GrantFiled: June 16, 1987Date of Patent: May 1, 1990Assignees: Trustees of Boston University, Angio-Medical Corp.Inventors: Nicholas Catsimpoolas, Ann L. Griffith, Robert S. Sinn
-
Patent number: 4895838Abstract: A method for causing or increasing angiogenesis is described. The method involves administering to a subject, such as a human being in need of angiogenesis an angiogenically effective amount of an angiogenically effective, pharmaceutically acceptable oligosaccharide or mixture of oligosaccharides.Type: GrantFiled: March 9, 1988Date of Patent: January 23, 1990Assignees: Trustees of Boston University, Angio-Medical CorporationInventors: Robert McCluer, Nicholas Catsimpoolas, Michael Klibaner, Ann Griffith, Robert Sinn
-
Patent number: 4888324Abstract: Compositions which contain lipid containing molecules possessing angiogenic activity are disclosed. The lipid containing molecules have been found in mammalian tissue, particularly the omentum, of various animals. Additionally, known lipids, such as gangliosides, are unexpectedly found to possess angiogenic activity. A method for obtaining the omentum-derived lipids, and for use of these and known lipids, are disclosed as well.Type: GrantFiled: November 2, 1987Date of Patent: December 19, 1989Assignees: Angio-Medical Corporation, Trustees of Boston UniversityInventors: Nicholas Catsimpoolas, Robert McCluer, Robert S. Sinn, James Evans
-
Patent number: 4879114Abstract: 36 Lipid extracts and lipid fractions from mammalian omenta containing mostly lipids are used cosmetically for skin conditions, skin care and cosmetic products which products have skin softening applications without skin irritation, greasiness or mutagenic effect. These materials with and without ganglioside are used for skin conditions such as keratosis, white spots and the like.Type: GrantFiled: December 20, 1985Date of Patent: November 7, 1989Assignee: Angio-Medical CorporationInventors: Nicholas Catsimpoolas, Ahmad R. Kamarei, Ann L. Griffith, Robert S. Sinn
-
Patent number: 4778787Abstract: Angiogenesis healing factors residing in omentum-derived lipid fractions with or without gangliosides or their synthetic equivalents can be used to treat myocardial ischemic conditions including but not limited to myocardial infarction, angina, as well as in heart transplant, vascular grafts, and re-opened vessels leading to improved vascularization, perfusion, collagenization and organization of said lesions; the involved and adjacent tissues.Type: GrantFiled: December 20, 1985Date of Patent: October 18, 1988Assignees: Trustees of Boston University, Angio-Medical CorporationInventors: Nicholas Catsimpoolas, Haralambos Gavras, Christian C. Haudenschild, Michael I. Klibaner
-
Patent number: 4769362Abstract: Lipid containing molecules and compositions, including gangliosides and omental tissue extracts had previously been found to be effective in increasing angiogenesis. It has now been found that these same materials cause increased localized perfusion in mammals. A method for providing increased perfusion, using these compositions, is presented herein.Type: GrantFiled: April 14, 1986Date of Patent: September 6, 1988Assignees: Trustees of Boston University, Angio-Medical CorporationInventors: Nicholas Catsimpoolas, Robert McCluer, James Evans, Robert S. Sinn
-
Patent number: 4767746Abstract: Omental lipid fractions accelerate wound healing especially as to epithelialization in mammals.Type: GrantFiled: December 4, 1985Date of Patent: August 30, 1988Assignees: Trustees of Boston University, Angio-Medical CorporationInventors: Nicholas Catsimpoolas, Robert S. Sinn
-
Patent number: 4766111Abstract: Plasmin inhibitory substances have been found in mammalian omental extracts. The substances all contain lipid components. In addition, related commercially available lipid containing molecules, such as mono-, di-, and trisialogangliosides are found to possess unexpected plasmin inhibitory properties. This suggests methods of therapy for diseases and conditions where blood clotting and fibrin degradation products, are implicated.Type: GrantFiled: March 23, 1987Date of Patent: August 23, 1988Assignee: Trustees of Boston UniversityInventor: Nicholas Catsimpoolas
-
Patent number: 4710490Abstract: Compositions which contain lipid containing molecules possessing angiogenic activity are disclosed. The lipid containing molecules have been found in mammalian tissue, particularly the omentum, of various animals. Additionally, known lipids, such as gangliosides, are unexpectedly found to possess angiogenic activity. A method for obtaining the omentum-derived lipids, and for use of these and known lipids, are disclosed as well.Type: GrantFiled: October 1, 1985Date of Patent: December 1, 1987Assignees: Angio Medical Corporation, Trustees of Boston UniversityInventors: Nicholas Catsimpoolas, Robert McCluer, Robert S. Sinn, James Evans
-
Patent number: 4699788Abstract: A novel angiogenic composition obtained from the omentum is provided which acts as a potent and effective factor for blood perfusion enhancement and for the development of new blood vessels in an organized structural network in living tissues. The angiogenic composition is a lipid or lipids, essentially protein-free as extracted from the omentum using organic solvents. This composition can then be injected to target to a site where new blood vessel formation, or blood perfusion enhancement is required. This material can be used to heal various damaged tissues including bone and heart.Type: GrantFiled: August 20, 1984Date of Patent: October 13, 1987Assignee: Trustees of Boston UniversityInventors: Nicholas Catsimpoolas, Harry S. Goldsmith
-
Patent number: 4673667Abstract: Plasmin inhibitory substances have been found in mammalian omental extracts. The substances all contain lipid components. In addition, related commercially available lipid containing molecules, such as mono-, di-, and trisialogangliosides are found to fossess unexpected plasmin inhibitory properties. This suggests methods of therapy for diseases and conditions where blood clotting and fibrin degradation products, are implicated.Type: GrantFiled: October 31, 1985Date of Patent: June 16, 1987Assignee: Trustees of Boston UniversityInventor: Nicholas Catsimpoolas
-
Patent number: 4500524Abstract: Seizures are inhibited or prevented and tranquilizing effect induced by administering riboflavin or a riboflavin analog, alone or in combination with a conventional anticonvulsant or tranquilizer to enhance its effect.Type: GrantFiled: August 11, 1983Date of Patent: February 19, 1985Assignee: Trustees of Boston UniversityInventor: Nicholas Catsimpoolas
-
Patent number: 4448150Abstract: An animal activity housing and monitor includes several vertically displaced levels of animal cages 32 which are angularly disposed about a core 28. The core is mounted for rotation relative to the animal cages and for fiberoptic communication with the cages. The fiberoptic filaments provide for at least one light beam to be sequentially transmitted across the cages within each level for detecting animal position. Surrounding the central core are animal activity stations 36 which may be used for animal weighing, feeding, or experimentation. The cage support structure 24 is mounted for rotational positioning so that cages may be positioned at animal activity stations 36.Type: GrantFiled: September 15, 1982Date of Patent: May 15, 1984Assignee: Trustees of Boston UniversityInventor: Nicholas Catsimpoolas
-
Patent number: 4375401Abstract: An improved electrophoresis system for simple, rapid and reproducible separations of biological materials such as proteins, nucleic acids, cells, bacteria, cell organelles, etc. is described. The system consists of several subsystems including a first dimensional system having a multi-column rotatable carousel with automatic density gradient maker and sample deposition, a unique fraction collector cassette which can serve as a sample applicator for the second dimension electrophoresis and a slab-gel second-dimensional electrophoresis system. The total system operation is integrated by microprocessor control. Flexibility in the system design and operation allows for running in an analytical or preparative mode at the discretion of the system operator.Type: GrantFiled: May 20, 1981Date of Patent: March 1, 1983Inventor: Nicholas Catsimpoolas